Vivo Capital »

Camp4 Therapeutics Corp shares owned by Vivo Capital

Quarter-by-quarter ownership of Camp4 Therapeutics Corp (CAMP) shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Camp4 Therapeutics Corp

Tip: Access up to 7 years of quarterly data

All positions including Camp4 Therapeutics Corp held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Camp4 Therapeutics Corp by Vivo Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $12M 3.9M 3.00

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Verona Pharma Sponsored Ads (VRNA)
Cidara Therapeutics Common (CDTX)
Terns Pharmaceuticals Common (TERN)
Trevi Therapeutics Common (TRVI)
Avadel Pharmaceuticals Adr (AVDL)
Cogent Biosciences Common (COGT)
Sinovac Biotech SHS
Oric Pharmaceuticals Common (ORIC)
Geron Corp Common (GERN)
Compass Therapeutics Common (CMPX)
Dyne Therapeutics Common (DYN)
Abivax SA - Sponsored Ads (ABVX)
Bright Minds Biosciences Common (DRUG)
Tourmaline Bio Common (TRML)

View all positions for Vivo Capital

Top funds holding Camp4 Therapeutics Corp

5AM Venture Management
Henderson Group
Vivo Capital
Enavate Sciences GP
FMR
AH Capital Management
Adage Capital Partners GP
HarbourVest Partners
Silverarc Capital Management
Vanguard Group
Alyeska Investment Group
Two Sigma Investments
Millennium Management
Victory Capital Management
Geode Capital Management

View all funds holding Camp4 Therapeutics Corp